Study Of Generalized Anxiety Disorder

Clinical trial NCT00135525 · COMPLETED

Trial details

NCT number: NCT00135525
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anxiety Disorder Anxiety Disorders

Start date: 2003-05-01
Primary completion: 2005-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.